these - Université de Franche-Comté

53 Speer CP, Robertson B, Curstedt T, Halliday HL, Compagnone D, Gefeller O, Harms
K, Herting E, McClure G, Reid M, et al.
Randomized European multicenter trial of surfactant replacement therapy for severe
neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
Pediatrics. 1992 Jan;89(1):13-20.
54 Herting E, Speer CP, Harms K, Robertson B, Curstedt T, Halliday HL, Compagnone
D, Gefeller O, McClure G, Reid M, et al.
Factors influencing morbidity and mortality in infants with severe respiratory distress
syndrome treated with single or multiple dses of a natural porcine surfactant.
Biol Neonate. 1992;61 Suppl 1:26-30.
55 De Winter JP, Egberts J, de Kleine MJ, van bel F, Wijnands JB, Guit GL. Prevention
and treatment of respiratory distress syndrome in premature infants using
intratracheally administrered surfactants.
Ned Tijdschr Geneeskd. 1992 Oct 10;136(41):2018-24.
56 Laboratoire Abbot division pédiatrie.
Survanta® :Surfactant naturellement.
Paris : Abbot ; 2003
57 La revue Prescrire®
Rubrique arrêts de commercialisation : Surfexo néonatal préparation pour instillation
intratrachéale
La revue Prescrire. 2003 Jul-Aug;23(241):507.
58 Ishisaka DY.
Exogenous surfactant use in neonates.
Ann Pharmacother. 1996 Apr;30(4):389-98.
143